德康医疗
DXCM
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
4
和黄医药
HCM
5
Dorian LPG
LPG
(FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | |
---|---|---|---|---|---|---|---|---|---|---|
营业总收入 | 4.74%17.36亿 | 4.55%4.61亿 | 4.95%4.38亿 | 2.17%4.22亿 | 7.50%4.15亿 | 22.19%16.58亿 | 20.97%4.41亿 | 21.69%4.17亿 | 23.19%4.13亿 | 23.10%3.86亿 |
营业收入 | 4.77%17.28亿 | 4.71%4.58亿 | 4.97%4.36亿 | 2.20%4.2亿 | 7.36%4.13亿 | 22.10%16.49亿 | 20.71%4.38亿 | 21.64%4.15亿 | 23.05%4.11亿 | 23.20%3.85亿 |
主营业务成本 | 4.23%15.6亿 | 2.77%4.13亿 | 4.53%3.93亿 | 2.08%3.8亿 | 7.90%3.74亿 | 22.45%14.96亿 | 22.60%4.02亿 | 21.53%3.76亿 | 23.28%3.72亿 | 22.41%3.47亿 |
毛利 | 9.51%1.77亿 | 22.86%4,796.7万 | 8.66%4,535.2万 | 3.02%4,268.4万 | 3.97%4,085万 | 19.82%1.62亿 | 6.34%3,904.1万 | 23.17%4,173.6万 | 22.43%4,143.3万 | 29.49%3,929.1万 |
营业费用 | 13.50%1.6亿 | 13.55%4,271.9万 | 9.22%3,953.9万 | 9.09%3,758.6万 | 22.87%4,002.7万 | -8.48%1.41亿 | 9.16%3,762.1万 | -5.88%3,620万 | -11.86%3,445.4万 | -22.23%3,257.7万 |
销售和管理费用 | 13.61%1.53亿 | 14.05%4,088.7万 | 9.50%3,774.2万 | 9.17%3,576.8万 | 22.31%3,820.6万 | -10.05%1.34亿 | 7.56%3,584.9万 | -7.61%3,446.9万 | -13.61%3,276.4万 | -23.38%3,123.7万 |
-销售费用 | 6.93%2,644.6万 | 3.41%646.2万 | -2.68%704.7万 | 15.04%685.2万 | 15.12%608.5万 | 25.28%2,473.2万 | 20.80%624.9万 | 42.32%724.1万 | 23.59%595.6万 | 13.41%528.6万 |
-管理费用 | 15.12%1.26亿 | 16.30%3,442.5万 | 12.73%3,069.5万 | 7.86%2,891.6万 | 23.78%3,212.1万 | -15.44%1.1亿 | 5.13%2,960万 | -15.49%2,722.8万 | -19.03%2,680.8万 | -28.13%2,595.1万 |
折旧摊销及损耗 | 11.25%726.8万 | 3.39%183.2万 | 3.81%179.7万 | 7.57%181.8万 | 35.90%182.1万 | 42.92%653.3万 | 56.12%177.2万 | 50.13%173.1万 | 45.06%169万 | 19.86%134万 |
-折旧及摊销 | 11.25%726.8万 | 3.39%183.2万 | 3.81%179.7万 | 7.57%181.8万 | 35.90%182.1万 | 42.92%653.3万 | 56.12%177.2万 | 50.13%173.1万 | 45.06%169万 | 19.86%134万 |
营业利润 | -17.76%1,698.2万 | 269.58%524.8万 | 5.00%581.3万 | -26.95%509.8万 | -87.74%82.3万 | 207.99%2,064.9万 | -36.86%142万 | 221.03%553.6万 | 232.93%697.9万 | 158.14%671.4万 |
净非营业利息收入(费用) | 30.05%1,088.8万 | -2.60%277.4万 | -25.22%216.4万 | 263.04%296.6万 | 64.59%298.4万 | 1,444.65%837.2万 | 147.22%284.8万 | 915.44%289.4万 | 223.23%81.7万 | 881.47%181.3万 |
利息收入 | ---- | ---- | -25.22%216.4万 | ---- | ---- | ---- | ---- | --289.4万 | ---- | ---- |
其他财务费用 | -30.05%-1,088.8万 | ---- | ---- | -263.04%-296.6万 | -64.59%-298.4万 | -1,444.65%-837.2万 | ---- | ---- | -223.23%-81.7万 | -881.47%-181.3万 |
其他净收入(费用) | ||||||||||
税前利润 | -3.97%2,787万 | 87.96%802.2万 | -5.37%797.7万 | 3.44%806.4万 | -55.35%380.7万 | 256.19%2,902.1万 | 25.49%426.8万 | 296.55%843万 | 231.85%779.6万 | 172.39%852.7万 |
所得税 | 35.44%1,082.6万 | 36.57%265.5万 | 60.73%399.9万 | 138.23%342.1万 | -64.66%75.1万 | 222.67%799.3万 | 114.46%194.4万 | 151.35%248.8万 | -73.74%143.6万 | -66.31%212.5万 |
除税后利润 | -18.95%1,704.4万 | 130.94%536.7万 | -33.05%397.8万 | -27.00%464.3万 | -52.26%305.6万 | 274.30%2,102.8万 | -86.21%232.4万 | 968.71%594.2万 | 155.88%636万 | 135.40%640.2万 |
持续经营利润 | -18.95%1,704.4万 | 130.94%536.7万 | -33.05%397.8万 | -27.00%464.3万 | -52.26%305.6万 | 274.30%2,102.8万 | -86.21%232.4万 | 968.71%594.2万 | 155.88%636万 | 135.40%640.2万 |
归属于少数股东的净利润 | 229.64%265.9万 | 288.33%96.8万 | 48.16%44.3万 | 228.67%117.6万 | 107.81%7.2万 | 41.05%-205.1万 | 44.61%-51.4万 | 128.00%29.9万 | -0.88%-91.4万 | -59.79%-92.2万 |
归属于母公司的净利润 | -37.67%1,438.5万 | 55.00%439.9万 | -37.36%353.5万 | -52.34%346.7万 | -59.26%298.4万 | 368.83%2,307.9万 | -84.03%283.8万 | 247.48%564.3万 | 169.44%727.4万 | 141.83%732.4万 |
优先股派息 | ||||||||||
其他优先股派息 | ||||||||||
归属于普通股股东的净利润 | -37.67%1,438.5万 | 55.00%439.9万 | -37.36%353.5万 | -52.34%346.7万 | -59.26%298.4万 | 368.83%2,307.9万 | -84.03%283.8万 | 247.48%564.3万 | 169.44%727.4万 | 141.83%732.4万 |
基本每股收益 | -40.00%0.12 | 100.00%0.04 | -40.00%0.03 | -50.00%0.03 | -50.00%0.03 | 350.00%0.2 | -87.50%0.02 | 400.00%0.05 | 160.00%0.06 | 137.50%0.06 |
稀释每股收益 | -42.11%0.11 | 50.00%0.03 | -40.00%0.03 | -50.00%0.03 | -66.67%0.02 | 337.50%0.19 | -85.71%0.02 | 400.00%0.05 | 160.00%0.06 | 137.50%0.06 |
每股派息 | ||||||||||
货币单位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
会计准则 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
审计意见 | 无保留意见 | -- | -- | -- | -- | 无保留意见 | -- | -- | -- | -- |